Dr Ethel Neill

Dr Ethel Neill 936k followers • 36 following

A study led by Ciara Duffy at the Harry Perkins Institute of Medical Research has revealed that honeybee venom contains ...
11/03/2026

A study led by Ciara Duffy at the Harry Perkins Institute of Medical Research has revealed that honeybee venom contains compounds capable of destroying aggressive breast cancer cells in laboratory testing. The findings were published in the scientific journal npj Precision Oncology.

Researchers identified melittin, the main active compound in bee venom, as the key factor behind the effect. In controlled experiments, melittin rapidly disrupted cancer cell membranes and interfered with critical signaling pathways such as EGFR and HER2 that drive tumor growth and division.

Animal studies also suggested that combining melittin with the chemotherapy drug Docetaxel improved tumor suppression compared to chemotherapy alone. While the findings are promising, scientists emphasize that further research and clinical trials are needed before this approach could be used in standard cancer treatments.

This post is Shared for informational/Entertainment purposes only, We do not own the rights to the content provided here

WHAT PARASITES ACTUALLY DO TO HUMANS ‎‎1.Parasites release neurotoxins and suppress the immune system.‎‎2. Parasites Ste...
08/03/2026

WHAT PARASITES ACTUALLY DO TO HUMANS

‎1.Parasites release neurotoxins and suppress the immune system.

‎2. Parasites Steal nutrients from the body,hence causing deficiencies in iron,B12, Zinc, and more.

‎3.parasites disrupt sleep cycles and cause anxiety or night wakings.

‎4. Parasites triggers chronic inflammation and autoimmunity

‎5.Parasites contribute to eczema,rashes, acne and skin issues.

‎6. Parasite increase histamine and cause food sensitivities.

‎7.Parasites burrows into human organs, causing pain and dysfunction.

‎8.Parasites impair liver detox,bile flow and digestion.

‎9.Parasites influence cravings(especially sugar and carbs).

You’re welcome to message me anytime about a parasite cleanse kit suitable for both adults and kids.

THE IVERMECTIN-PAK1 CONNECTION: DISRUPTING THE CANCER "ENGINE" 🧬 (Study: PMC7505114)In the high-stakes world of metaboli...
08/03/2026

THE IVERMECTIN-PAK1 CONNECTION: DISRUPTING THE CANCER "ENGINE" 🧬 (Study: PMC7505114)

In the high-stakes world of metabolic oncology, we often talk about "killing" malignant cells. But what if the real secret to survival is disabling their ability to move and grow in the first place?

Peer-reviewed research, specifically study PMC7505114, has identified a critical vulnerability in over 70% of aggressive cancers: a protein called PAK1.

✅What is PAK1? The "Engine and Navigator"

Think of a malignant cell as a vehicle. PAK1 is both its engine and its GPS system.

➡️The Engine: It provides the energy and signals for rapid cell division (tumor growth).

➡️The Navigator: It triggers a process called EMT (Epithelial-Mesenchymal Transition), allowing cells to "uncouple" from the primary tumor and travel to other organs. This is how metastasis starts.

➡️The Breakthrough: Ivermectin as a Molecular "Kill-Switch"

The data shows that the molecule Ivermectin acts as a potent inhibitor of this PAK1 protein. By shutting down this specific pathway, the molecule effectively:

✅ Freezes the Engine: Slows down the rapid expansion of the tumor mass.
✅ Blocks the Navigator: Prevents the EMT process, keeping cells "anchored" and unable to invade other tissues.
✅ Strips the Armor: Makes the "immobilized" cells significantly more vulnerable to the body's natural immune defenses.

✨Want my full cancer healing guide ?
Comment “PROTOCOL” or “SEND” me a Dm Dr Ethel Neill




20 Warning Signs That Cancer May Be Growing in Your BodyCancer often develops silently, but your body may give you early...
07/03/2026

20 Warning Signs That Cancer May Be Growing in Your Body

Cancer often develops silently, but your body may give you early warning signs. Ignoring these symptoms could be risky! If you notice any of the following, it’s time to take action:

1️⃣ Unexplained Weight Loss – Losing weight without diet or exercise changes.
2️⃣ Persistent Fatigue – Feeling exhausted despite rest.
3️⃣ Lumps or Swellings – Unusual lumps anywhere on your body.
4️⃣ Skin Changes – Dark spots, sores that don’t heal, or changes in moles.
5️⃣ Chronic Cough or Hoarseness – Lasting longer than three weeks.
6️⃣ Blood in Urine or Stool – Could indicate colon, bladder, or kidney cancer.
7️⃣ Difficulty Swallowing – May signal throat or esophageal cancer.
8️⃣ Persistent Indigestion – Ongoing bloating or stomach pain.
9️⃣ Changes in Bowel Habits – Long-term constipation or diarrhea.
🔟 Unusual Bleeding – Between periods or post-menopause bleeding.
1️⃣1️⃣ Breast Changes – Lumps, ni**le discharge, or skin dimpling.
1️⃣2️⃣ Frequent Infections – A weakened immune system can be a sign.
1️⃣3️⃣ Joint or Bone Pain – Persistent, unexplained pain.
1️⃣4️⃣ Mouth Sores That Don’t Heal – Especially in smokers.
1️⃣5️⃣ Night Sweats & Fever – Without an infection.
1️⃣6️⃣ Neurological Symptoms – Blurred vision, headaches, or numbness.
1️⃣7️⃣ Testicular or Prostate Changes – Pain, swelling, or discomfort.
1️⃣8️⃣ Pelvic Pain – Can indicate ovarian or cervical cancer.
1️⃣9️⃣ Persistent Back Pain – Unrelated to injury.
2️⃣0️⃣ Shortness of Breath – A sign of lung cancer.

⚠️ Your body is always communicating with you—don’t ignore these signals! Early detection is key to better outcomes. If you or a loved one are experiencing any of these, seek guidance from a trusted professional.

🔬 Want to learn about alternative treatments or natural protocols? Reach out to Dr Ethel Neill today! Let’s talk of your health💪💪

Triple Combination Of Ivermectin, Mebendazole and Fenbendazole For Cancer. Abstract✅Background: Drug repurposing is gain...
07/03/2026

Triple Combination Of Ivermectin, Mebendazole and Fenbendazole For Cancer.

Abstract

✅Background:
Drug repurposing is gaining attention in oncology. Antiparasitic agents such as ivermectin, fenbendazole, and mebendazole have demonstrated preclinical anticancer activity. The potential synergy of these agents as a triple combination is of increasing interest.

✅Objective:
To review mechanistic rationale, preclinical evidence, and human observational data supporting the triple combination of ivermectin, fenbendazole, and mebendazole in cancer and discuss research gaps and limitations.

✅Methods:
Mechanistic studies, preclinical research, and publicly reported case testimonials were reviewed. Human evidence was synthesized using a PRISMA-style framework.

✅Results:
Preclinical studies demonstrate complementary mechanisms of action across all three agents. 10 publicly reported cases of triple anti-parasitic therapy and one case of quadruple anti-parasitic therapy suggest temporal associations with tumor shrinkage or biomarker improvements, though all are uncontrolled and confounded by prior or concurrent therapies.

✅Conclusion:
While biologically plausible, the ivermectin–fenbendazole–mebendazole combination remains investigational. Observations are hypothesis-generating and warrant controlled preclinical studies and exploratory clinical trials before clinical adoption

✅Mechanistic Rationale: The Triple Combination Approach

The triple combination is based on complementary anticancer mechanisms:

➡️Microtubule Disruption: Fenbendazole and Mebendazole inhibit microtubule polymerization, leading to mitotic arrest and apoptosis (programmed cell death) (OneDayMD, 2026).

➡️Metabolic Interference: Fenbendazole impairs glucose uptake via GLUT1/hexokinase inhibition, effectively disrupting the energy supply of cancer cells.

➡️Oncogenic Signaling Inhibition: Ivermectin targets STAT3, Wnt/β-catenin, AKT/mTOR, and YAP pathways, potentially enhancing programmed cell death and immune modulation.

➡️Anti-angiogenic Activity: Mebendazole suppresses VEGF-mediated angiogenesis, limiting the tumor's ability to form new blood vessels.

➡️Cancer Stem Cell Targeting: Both Mebendazole and Ivermectin may reduce tumor recurrence and drug resistance by targeting cancer stem cells.

➡️Pharmacokinetic Complementarity: Mebendazole has better-established human dosing and bioavailability, while Fenbendazole is widely available and increasingly reported in anecdotal clinical cases.

This multi-axis interference underpins the hypothesis that the triple combination may produce synergistic anticancer effects.

✨Want a full terrain healing guide ?
Comment “PROTOCOL”

What can Fenbendazole help with?Pancreatic cancer Colorectal cancer Ovarian cancer Glioblastoma multiforme Small-cell lu...
07/03/2026

What can Fenbendazole help with?

Pancreatic cancer
Colorectal cancer
Ovarian cancer
Glioblastoma multiforme
Small-cell lung cancer
Non-small cell lung cancer
Lymphoma
Prostate cancer
Breast cancer
Bladder cancer
Melanoma
Leukemia
Hepatocellular carcinoma
Renal cell carcinoma
Head and neck cancer
General anticancer effects
Reducing inflammation
Supporting immune system function
Improving autoimmune conditions
Alleviating arthritis symptoms
Enhancing gut microbiota
Neuroprotection
Antiviral effects
Antifungal effects
Metabolic syndrome improvement
Chronic fatigue syndrome relief
Anti-aging effects
Liver function support
Cardiovascular health support
+ Parasite removal.

Get Fenbendazole Available Now!!
Dr Ethel Neill





🦠Targeting Cancer Stem Cells (CSCs): Repurposed Agents and Supplements 💊(Open picture to see all) The table presents a s...
07/03/2026

🦠Targeting Cancer Stem Cells (CSCs): Repurposed Agents and Supplements 💊

(Open picture to see all)

The table presents a summary of novel drugs and nutraceuticals that have demonstrated the ability to target cancer stem cells (CSCs).

The list covers a diverse group of substances—from antiparasitic and metabolic drugs to vitamins—detailing their key mechanisms of action, such as inhibition of angiogenesis and induction of apoptosis.

MEBENDAZOLE: A POTENTIAL BREAKTHROUGH FOR BRAIN TUMORS 🧠🔬When it comes to brain cancer, the biggest challenge is the blo...
06/03/2026

MEBENDAZOLE: A POTENTIAL BREAKTHROUGH FOR BRAIN TUMORS 🧠🔬

When it comes to brain cancer, the biggest challenge is the blood-brain barrier—the body’s natural shield that blocks most chemotherapy. However, recent scientific evidence suggests that a common, low-cost drug called Mebendazole may hold the key to crossing this barrier and targeting malignant cells directly.

How it works against Brain Tumors:

Research from institutions like Johns Hopkins (Patent US 11,110,079 B2) and various Phase I clinical trials shows that Mebendazole works by disrupting the microtubules—the structural "scaffolding" of cancer cells. Without this scaffolding, the cells cannot divide and eventually die through apoptosis. 📉

THE CLINICAL PROOF: HUMAN STUDIES

The promise of Mebendazole isn’t just theoretical—it is currently being tested on humans in high-level clinical trials across the globe.

✅ Case Study (NCT03628079):

This Phase I study at the University of California, San Francisco (UCSF) specifically investigates the safety and effectiveness of Mebendazole in patients with Glioblastoma (GBM). The study focuses on how Mebendazole can work alongside standard chemotherapy to improve survival rates.

Key Clinical Data:

✅ Crossing the Barrier: Unlike many standard treatments, Mebendazole effectively penetrates the brain tissue.

✅ Inhibiting Growth: Studies on Glioblastoma (GBM) models indicate that it can significantly slow down tumor growth and reduce the risk of recurrence.

✅ Synergy: It is often studied in combination with standard care to enhance the overall effectiveness of the treatment.

Why is a drug that has been safely used for decades as a dewormer showing such promise in neuro-oncology? The science is there, but the question remains: why is it not yet a standard part of the conversation?

✨Want a full terrain healing guide ?
Comment “PROTOCOL”

NEW ARTICLE: IVERMECTIN and MEBENDAZOLE Testimonial - 63 year old woman with Stage 4 Ovarian Cancer metastatic to perito...
06/03/2026

NEW ARTICLE: IVERMECTIN and MEBENDAZOLE Testimonial - 63 year old woman with Stage 4 Ovarian Cancer metastatic to peritoneum sees CA125 drop from 2138 to 357, most cancer gone on PET!

Beware of inexperienced Integrative MDs who want to play with Ivermectin and Fenbendazole! 🤔

This is a success story that almost wasn't.

63 year old woman with Stage 4 Ovarian Cancer metastatic to peritoneum.

In early October 2024, she saw an integrative MD who put her on low dose Ivermectin (24mg) and Fenbendazole 300-600mg, eventually increasing to 1000mg a day.

Her CA125 increased from 1097 to 1668
(+ Fenben/IVM) to 2628.5 by mid Nov.2024!

Her CA125 rose from 1668 to 2628 after being on Fenbendazole and low dose Ivermectin for over a month!

Then she came to me. 😃

I switched her from 1000mg Fenbendazole to 1000mg Mebendazole and increased the Ivermectin from 24mg to 72mg.

Her CA125 from that point onwards:
2628.5 to 853 to 619 to 357 (!!)

PET/CT Scan done March 11, 2025 showed:

“extensive peritoneal carcinomatosis seen previously is essentially resolved”

“retroperitoneal adenopathy seen previously has returned to normal”

“left axillary adenopathy seen previously has resolved on both CT and PET images”

“most of the pelvic adenopathy seen previously has returned to normal on CT and PET”

“suspected capsular implant seen previously at the posterior aspect of the spleen is no longer visible on CT or PET”

Lesson:

Most Integrative MDs don’t know what they’re doing when it comes to Ivermectin and Benzimidazoles. They get the dosing and combinations wrong.

This patient wasn’t responding to low doses of Ivermectin or Fenbendazole and the Integrative MD increased the Fenbendazole dose to 1000mg, but the CA125 rose regardless, from 1097 to 2628! 😮

Ovarian Cancer is known to respond to Mebendazole and Ivermectin but South Korean researchers discovered it doesn’t respond well to Fenbendazole.

Some health professionals are attracted to the promise of repurposed drugs but wouldn’t know what to do at the sign of first trouble with their Protocol. Imagine coming to a health professional who has no idea what to do when their Ivermectin Protocol fails.

You wouldn't go to an inexperienced hairdresser, barber, or car mechanic, for an important job.

And what's more important than Stage 4 Cancer?

That’s why lots of Cancer patients come to me for assistance. They seek the unique expertise I provide.
Dr Ethel Neill

06/03/2026

✅ IVERMECTIN EVIDENCE

IVERMECTIN: A Potential Breakthrough in Colorectal Cancer Treatment?

The scientific evidence regarding the anticancer properties of Ivermectin is becoming impossible to ignore. A landmark study (Reference: PMID: 34335261 / DOI: 10.3389/fphar.2021.717529) has uncovered how this well-known, affordable drug can "reprogram" cancer cells, forcing them into self-destruction.

📈How It Works: The Molecular Science
Ivermectin doesn’t just attack cells blindly; it targets the very foundations of cancer's survival through several key mechanisms:

✅Induction of Apoptosis (Programmed Cell Death): The research shows that Ivermectin drastically increases the production of Reactive Oxygen Species (ROS) within tumor cells. This creates overwhelming oxidative stress that damages the cancer's mitochondria, forcing the cell to dismantle itself from the inside out.

✅Cell Cycle Arrest: The study proves that Ivermectin "freezes" the cancer cell cycle in the G0/G1 phase. This stops the cancer’s ability to divide and multiply, effectively halting tumor growth.

✅Inhibition of the Wnt/β-catenin Pathway: Beyond just killing cells, Ivermectin has been shown to inhibit the specific signaling pathways that colorectal cancer uses to grow and spread (metastasize) to other organs.

✅Synergistic Effects: Perhaps most importantly, Ivermectin may help overcome multidrug resistance, making standard chemotherapies more effective when used in combination.

🌍 Why Isn't This Mainstream News?
Ivermectin is a generic, off-patent drug, meaning it is incredibly inexpensive to produce. In a medical landscape often driven by high-profit margins, "drug repurposing"—finding new uses for old, cheap medicines—rarely receives the massive marketing and media backing that billion-dollar new patents do.

⚠️ A Critical Perspective
While these findings in laboratory (in vitro) and animal (in vivo) models are groundbreaking, it is important to note that clinical trials in humans are still ongoing. Researchers are working to determine the exact dosages required to replicate these results safely in oncology patients.

Official Source for Verification: Search for PMID: 34335261 on PubMed to read the full peer-reviewed study.

———————————————————————————

Educational purposes only. Always consult your oncology team before making any changes to your treatment. Dr Ethel Neill

✨Want my full cancer healing guide ?
Comment “PROTOCOL”




🔥💊IVERMECTIN in Combination with Targeted Therapy ‼️‼️🎖️While targeted therapies represent a massive leap in cancer trea...
06/03/2026

🔥💊IVERMECTIN in Combination with Targeted Therapy ‼️‼️🎖️

While targeted therapies represent a massive leap in cancer treatment, "Multidrug Resistance" (MDR) remains the primary cause of treatment failure. New evidence (References: PMID: 34335261 / PMC7505114) confirms that Ivermectin acts as a powerful strategic partner, enhancing the efficacy of advanced targeted drugs.

‼️Breaking the Defense: How Ivermectin Enhances Targeted Care‼️

1️⃣ Inhibition of Efflux Pumps: Cancer cells often survive targeted therapy by "pumping" the medicine out via P-glycoprotein. Ivermectin effectively blocks these pumps, keeping the targeted agent inside the tumor cell to maximize its lethal effect.

2️⃣ Sensitizing the Enemy (EGFR & Kinase Inhibitors):
Lung Cancer: Ivermectin targets the HSP27 protein, making resistant lung cancer cells significantly more vulnerable to EGFR inhibitors like Erlotinib.
Liver & Breast Cancer: When combined with kinase inhibitors such as Sorafenib or Lapatinib, Ivermectin produces a synergistic anti-tumor response far greater than either drug alone. 📉

3️⃣ Mitochondrial Disruptor: Ivermectin attacks the cancer cell’s energy source, making it nearly impossible for the tumor to repair itself while under attack from targeted therapies.

4️⃣ Induction of Autophagy: Ivermectin doesn't just damage cancer cells; it triggers "self-eating" (autophagy) in resistant populations, forcing the tumor to digest its own structures while under pressure from targeted treatment.

The Clinical Reality: Despite compelling molecular evidence, using an affordable, off-patent drug to boost the performance of expensive targeted therapies is a concept that challenges the current economic model of "Big Pharma."

This information is for educational purposes only and reflects preclinical research. Dr Susanne Garcia

✨Want my full cancer healing guide ?
Comment “PROTOCOL” or “SEND” me a Dm



20 SIGNS YOU MIGHT HAVE PARASITES 1. *Digestive issues* – diarrhea, constipation, gas, or bloating  2. *Unexplained weig...
06/03/2026

20 SIGNS YOU MIGHT HAVE PARASITES

1. *Digestive issues* – diarrhea, constipation, gas, or bloating
2. *Unexplained weight loss*
3. *Fatigue or exhaustion*
4. *Frequent hunger or never feeling full*
5. *Skin issues* – rashes, eczema, hives, or itching
6. *Stomach pain or cramping*
7. *Nausea or vomiting*
8. *Teeth grinding (especially at night)*
9. *Itching around the a**s* (especially at night)
10. *Nutritional deficiencies* – iron, B12, etc.
11. *Mood changes* – anxiety, depression, irritability
12. *Sleep disturbances or insomnia*
13. *Muscle or joint pain without a clear cause*
14. *Brain fog or difficulty concentrating*
15. *Frequent yeast infections or UTIs*
16. *Bad breath or body odor*
17. *Food sensitivities or allergies*
18. *Swollen lymph nodes*
19. *Weakened immune system – frequent colds or infections*
20. *Visible worms in stool or around the a**s*

✨Want a full PARASITE CLEANSE/DETOX Protocol?
Comment “PROTOCOL” or “SEND” me an inbox 📥 Dr Ethel Neill

Address

Totton
Southampton

Telephone

+12253024970

Website

Alerts

Be the first to know and let us send you an email when Dr Ethel Neill posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Dr Ethel Neill:

Share